Item 6. Selected Financial Data



	Years Ended December 31
(In millions, except per share amounts)	2017			2016			2015			2014			2013
Operating Results
Net sales	$	6,380		$	6,038		$	5,695		$	5,881		$	6,227
Operating earnings (loss)	1,282			1,067			994			(1,006		)	947
Earnings (loss) from continuing operations, net of tax*	(155		)	560			640			(697		)	933
Per Share Data (in dollars)
Diluted earnings (loss) from continuing operations per common share*	$	(0.95	)	$	3.24		$	3.17		$	(2.84	)	$	3.45
Earnings (loss) per diluted common share*	(0.95		)	3.24			3.02			5.29			4.06
Diluted weighted average common shares outstanding (in millions)	162.9			173.1			201.8			245.6			270.5
Dividends declared per share	$	1.93		$	1.70		$	1.43		$	1.30		$	1.14
Balance Sheet
Total assets	$	8,208		$	8,463		$	8,346		$	10,423		$	11,851
Total debt	4,471			4,396			4,349			3,400			2,461
Other Data
Capital expenditures	$	227		$	271		$	175		$	181		$	169
% of sales	3.6		%	4.5		%	3.1		%	3.1		%	2.7		%
Research and development expenditures	$	568		$	553		$	620		$	681		$	761
% of sales	8.9		%	9.2		%	10.9		%	11.6		%	12.2		%